Medical Device News Magazine

Gastroenterology Group of Naples Announces the Introduction of Axonics Sacral Neuromodulation Therapy

New Treatment Option Offers Long-Term Relief for Those Suffering from Gastrointestinal Disorders

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Gastroenterology Group of Naples

Gastroenterology Group of Naples, a partner practice of United Digestive, is pleased to announce the introduction of Axonics Sacral Neuromodulation Therapy to its list of advanced treatment options for those suffering from fecal incontinence. This innovative therapy involves a minimally invasive outpatient procedure in which a device is implanted that helps to restore normal communication between the brain and bowel by gently stimulating nerves. This nerve stimulation can result in symptom improvement.
Dr. Rafael Urbina of the Gastroenterology Group of Naples explains that Axonics Therapy represents a significant advancement in the field of gastroenterology.

Axonics Therapy

“At Gastroenterology Group of Naples, we are committed to staying at the forefront of medical innovation to ensure that our patients receive the highest standard of care. Axonics Therapy represents a significant advancement in our field and heralds a new era in gastroenterology, offering patients a transformative alternative for managing certain specific gastrointestinal disorders.”

This new therapy provides an alternative solution for patients who have not found success with traditional treatments, as well as the potential for long-term relief and improved quality of life.

Dr. Rafael Urbina of the Gastroenterology Group of Naples

“This innovative approach provides hope and relief for those who have not found success with conventional treatments. Many patients with gastrointestinal disorders experience significant disruptions in their daily lives. We can now offer them a minimally invasive solution that can significantly improve their quality of life.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”